Vilin Bio Med Limited
Fixed Price IPO · NSE
- Price band
- ₹30 - ₹30
- Lot size
- 4,000 shares
- Issue amount
- ₹12 cr
- Total subscription
- 2.82×
- Opens
- 16 Jun 2023
- Closes
- 21 Jun 2023
- Allotment
- 26 Jun 2023
- Listing
- 30 Jun 2023
Offer at a glance
Issue overview
- Issue size
- 40,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,20,000
- Fresh issue
- ₹12 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,20,000
- Issue type
- Fixed Price IPO
- Shares before issue
- 99,50,000
- Shares after issue
- 1,39,50,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 4,000 | ₹1,20,000 |
| HNI | 2 | 8,000 | ₹2,40,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| RETAIL | 6 | 24.12 |
| NIB | 5.38 | 7.93 |
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Values |
|---|---|
| EPS | 0.1 |
| ROE | 14.76 |
| ROCE | 8.58 |
| RONW | 1.15 |
| PRE IPO(PE) | 24.59 |
| POST IPO(PE) | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic manufacturing of pharmaceutical products, supplying in bulk to pharmaceutical manufacturers, marketers, and traders who distribute them to end customers. The company’s product range includes Oral Liquids (Syrups, Suspensions, Dry Powders – both βeta and Non-βeta-Lactam), Tablets and Capsules (βeta and Non-βeta-Lactam), External Preparations, and Dry Powders. Vilin Bio Med operates its R&D center and manufacturing facility in Roorkee, Uttarakhand, ensuring quality and innovation in production. The company reported revenue of ₹1,121.91 lakhs in FY2022 and ₹1,171.88 lakhs in FY2021.
Promoters
Viswa Prasad Sadhanala
Sadhanala Venkata Rao
D. Srinivasa Reddy
Ramesh Reddy Sama
Registrar & documents
Lead manager
Inventure Merchant Banker Services Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
Sy.No.115/GF/J, Hanumanji Colony, Brig Sayeed Road, Bowempally, Secunderabad – 500003
+91 40 7961 8843
[email protected]Company website ↗Frequently Asked Questions
What is Vilin Bio Med IPO GMP today?
Currently, Vilin Bio Med IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹30. Track daily updates on IPO Premiums as bidding numbers unfold.
What is the lot size and minimum investment for Vilin Bio Med IPO?
The minimum bid lot size for Vilin Bio Med IPO is 4,000 shares. At the cut-off price of ₹30 per share, retail investors need a minimum application amount of ₹1,20,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Vilin Bio Med IPO allotment status be announced?
The allotment status for Vilin Bio Med IPO is scheduled to be finalized on 26 Jun 2023. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Vilin Bio Med IPO allotment status online by PAN?
To check Vilin Bio Med IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Vilin Bio Med Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.